CNSY · Cerenome, Inc. · Executive Compensation
$1.60
-0.18 (-10.11%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$15.10M
Shares
7.59M
Volume · Oct 2
234.62K
Avg daily vol (3M)
120.31K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Marc H. Hedrick | President and Chief Executive Officer | $954,651 |
| Norman LaFrance | Chief Medical Officer | $637,811 |
| Andrew Sims | Chief Financial Officer | $446,176 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Marc H. Hedrick | President and Chief Executive Officer | $1,667,279 |
| Andrew Sims | Chief Financial Officer | $845,091 |
| Norman LaFrance | Chief Medical Officer | $292,704 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Marc H. Hedrick | President and Chief Executive Officer | $1,132,430 |
| Andrew Sims | Chief Financial Officer | $412,953 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Marc H. Hedrick | M.D., President and Chief Executive Officer | $867,428 |
| Tiago M. Girão | Former Chief Financial Officer and SVP of Operations | $109,211 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Marc H. Hedrick | M.D., President and Chief Executive Officer | $614,978 |
| Tiago M. Girão | Former Chief Financial Officer and SVP of Operations | $354,587 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eric J. Daniels | Chief Development Officer | Appointed | 2026-04-09 |
| Robert Lenk | member of the Board and a member of the Nominating and Corporate Governance Committee | Resigned | 2026-03-26 |
| Ronald A. Andrews | director of the Board | Appointed | 2026-03-26 |
| Greg Petersen | member of the Board | Resigned | 2025-04-18 |
| Kyle Guse | director of the Board | Appointed | 2025-04-18 |
| Dr. Norman LaFrance | Chief Medical Officer | Resigned | 2024-06-07 |